Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.45 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.45 |
| ▸ | TAS1R2 | Q8TE23 | 2/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | SMARCA2 | P51531 | 5/20 | 0.44 |
| ▸ | SMARCA4 | P51532 | 4/20 | 0.44 |
| ▸ | PROKR1 | Q8TCW9 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | KDM6B | O15054 | 1/20 | 0.41 |
| ▸ | TET3 | O43151 | 1/20 | 0.41 |
| ▸ | KDM4A | O75164 | 1/20 | 0.41 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | KDM5A | P29375 | 1/20 | 0.41 |
| ▸ | KDM5C | P41229 | 1/20 | 0.41 |
| ▸ | ASPH | Q12797 | 1/20 | 0.41 |
| ▸ | KDM4D | Q6B0I6 | 1/20 | 0.41 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.41 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6066419 | 0.98 | TAS1R3 (0.44) | TAS1R3TAS1R1TAS1R2RECQLSMARCA2 | |
| SCHEMBL27623752 | 0.84 | RECQL (0.47) | TAS1R3TAS1R1TAS1R2RECQLSMARCA2 | |
| SCHEMBL9446705 | 0.83 | CYP11B1 (0.46) | TAS1R3TAS1R1TAS1R2RECQLSMARCA2 | |
| SCHEMBL14204663 | 0.83 | TAS1R3 (0.45) | TAS1R3TAS1R1TAS1R2RECQLSMARCA2 | |
| SCHEMBL40123 | 0.83 | KDM4C (0.61) | TAS1R3TAS1R1TAS1R2RECQLKDM4E | |
| SCHEMBL31547893 | 0.81 | KDM4C (0.59) | TAS1R3TAS1R1TAS1R2RECQLKDM4E | |
| SCHEMBL29640105 | 0.81 | SMARCA2 (0.49) | TAS1R3TAS1R1TAS1R2RECQLSMARCA2 | |
| SCHEMBL1569241 | 0.81 | CCNC (0.50) | TAS1R3TAS1R1TAS1R2RECQLSMARCA2 | |
| SCHEMBL7842106 | 0.81 | RECQL (0.48) | TAS1R3TAS1R1TAS1R2RECQLSMARCA2 | |
| SCHEMBL29642415 | 0.81 | CCNC (0.50) | TAS1R3TAS1R1TAS1R2RECQLSMARCA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 622 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108977192-A | A kind of surface ligand is the preparation method of the quantum dot of deprotonation amine | TCL集团股份有限公司 | 2018-12-11 | — | — | CN | claimed |
| JP-62265265-A | — | — | None | — | — | JP | disclosed |
| JP-2229161-A | — | — | None | — | — | JP | disclosed |
| JP-63275566-A | — | — | None | — | — | JP | disclosed |
| JP-63301868-A | — | — | None | — | — | JP | disclosed |
| EP-4725942-A1 | COMPOUNDS ACTIVE ON CYCLIN D1 PATHWAY AND THEIR USE | Sibylla Biotech S.p.A. (IT) | 2026-04-15 | — | — | EP | disclosed |
| EP-3609888-B1 | FARNESOID X RECEPTOR AGONISTS AND USES THEREOF | LILLY CO ELI (US) | 2025-08-27 | — | — | EP | disclosed |
| EP-4596041-A2 | FARNESOID X RECEPTOR AGONISTS AND USES THEREOF | Organovo, Inc. (US) | 2025-08-06 | — | — | EP | disclosed |
| US-20250051320-A1 | CRBN LIGANDS AND USES THEREOF | KYMERA THERAPEUTICS, INC. | 2025-02-13 | — | — | US | disclosed |
| CN-110637015-B | Fanisole X receptor agonist and application thereof | 奥加诺沃公司 | 2024-04-02 | — | — | CN | disclosed |
| JP-S63301868-A | N-(2-CHLOROISONICOTINOYL)AMINO ACID DERIVATIVE AND AGRICULTURAL AND HORTICULTURAL FUNGICIDE COMPRISING SAID DERIVATIVE AS ACTIVE INGREDIENT | NIPPON KAYAKU CO LTD | 1988-12-08 | — | — | JP | disclosed |
| JP-S63275566-A | N-(2-CHLOROISONICOTINOYL)AMINO ACID DERIVATIVE AND AGRICULTURAL AND HORTICULTURAL FUNGICIDE CONTAINING SAID DERIVATIVE AS ACTIVE COMPONENT | NIPPON KAYAKU CO LTD | 1988-11-14 | — | — | JP | disclosed |
| US-4736037-A | 2-halo-aryl-pyridinemethanols with analgesic or antiinflammatory activity | LACER, S.A. (ES) | 1988-04-05 | — | — | US | disclosed |
| EP-0246507-A1 | N-cyanoalkylisonicotinamide derivatives | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1987-11-25 | — | — | EP | disclosed |
| JP-S62265265-A | N-CYANOALKYLISONICOTINIC ACID AMIDE DERIVATIVE AND AGRICULTURAL AND HORTICULTURAL BACTERICIDE CONTAINING SAID DERIVATIVE AS ACTIVE COMPONENT | NIPPON KAYAKU CO LTD | 1987-11-18 | — | — | JP | disclosed |
| US-4690934-A | N-phenylsulfonylisonicotinamide derivatives and their use as fungicides or bactericides | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1987-09-01 | — | — | US | disclosed |
| US-4614833-A | 2-halo-pyridines | LACER, S.A. (ES) | 1986-09-30 | — | — | US | disclosed |
| US-4514408-A | INHIBITORS OF GASTRIC SECRETION | SANOFI (FR) | 1985-04-30 | — | — | US | disclosed |
| EP-0032516-B1 | NEW 2-HALO-PYRIDINES, THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS | LACER, S.A. (ES) | 1984-05-02 | — | — | EP | disclosed |
| EP-0032516-A1 | New 2-halo-pyridines, their production and pharmaceutical compositions | LACER, S.A. (ES) | 1981-07-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250051320-A1 | CRBN LIGANDS AND USES THEREOF | CRBN, CRKL, ERBB3 | TAS1R3 3062/4885TAS1R1 3288/4885TAS1R2 3394/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.